Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Journal of General Virology|October 22, 2008
Dominant negative mutant cyclin T1 proteins that inhibit HIV transcription by forming a kinase inactive complex with TatJulie K Jadlowsky, Masanori Nojima, Takashi Okamoto, et al.
Retrovirology|July 16, 2008
Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading TatJulie K Jadlowsky, Masanori Nojima, Antje Schulte, et al.
Clinical and Experimental Medicine|April 26, 2020
Clinical practice: chimeric antigen receptor (CAR) T cells: a major breakthrough in the battle against cancerStefan Lundh, In-Young Jung, Alexander Dimitri, et al.
Human Vaccines & Immunotherapeutics|February 9, 2019
CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapyJanuary Salas-Mckee, Weimin Kong, Whitney L Gladney, et al.
Cancer Immunology Research|July 17, 2024
Regulatory Considerations for Genome-Edited T-cell TherapiesJulie K Jadlowsky, Ju-Fang Chang, David H Spencer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2017
Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology PatientsKatherine T Marcucci, Julie K Jadlowsky, Wei-Ting Hwang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2020
Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected IndividualsJeffrey M Jacobson, Julie K Jadlowsky, Simon F Lacey, et al.
Cell Reports. Medicine|May 24, 2023
Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumorsIn-Young Jung, Estela Noguera-Ortega, Robert Bartoszek, et al.
Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.
Pageof 3